Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on ...
Investor's Business Daily on MSN43m
Biotech Stocks Dive After Trump Tacks On 20% European Tariff. Why AbbVie, Merck Could Be Exposed.Biotech stocks toppled late Wednesday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...
President Donald Trump has expressed irritation over Ireland’s role as a major exporter of drugs to the US. Botox users may ...
MAYO TD Paul Lawless has called for an immediate cut to commercial rates for businesses amid growing concern over the impact of new US tariffs on EU pharmaceutical goods. The Aontú TD accused the ...
Zacks Investment Research on MSN8h
AbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold?AbbVie ABBV stock has gained 16.1% so far this year compared with an increase of 4.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.
AbbVie’s stock is climbing like your caffeine intake before a deadline, gaining traction despite a 0.60% dip over the past ...
Eli Lilly and Company, Corcept Therapeutics, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks represent the publicly ...
AbbVie, Thermo Fisher Scientific, and Moderna are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks represent shares of companies that focus on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback